25 XP   0   0   10

aTyr Pharma Inc
Buy, Hold or Sell?

Let's analyse aTyr Pharma Inc together

PenkeI guess you are interested in aTyr Pharma Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of aTyr Pharma Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about aTyr Pharma Inc

I send you an email if I find something interesting about aTyr Pharma Inc.

Quick analysis of aTyr Pharma Inc (30 sec.)










What can you expect buying and holding a share of aTyr Pharma Inc? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€1.23
Expected worth in 1 year
€1.50
How sure are you?
27.8%

+ What do you gain per year?

Total Gains per Share
€0.26
Return On Investment
14.3%

For what price can you sell your share?

Current Price per Share
€1.83
Expected price per share
€1.43 - €2.38
How sure are you?
50%

1. Valuation of aTyr Pharma Inc (5 min.)




Live pricePrice per Share (EOD)

€1.83

Intrinsic Value Per Share

€-7.51 - €-8.83

Total Value Per Share

€-6.28 - €-7.59

2. Growth of aTyr Pharma Inc (5 min.)




Is aTyr Pharma Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$90.4m$83.2m$17.8m17.6%

How much money is aTyr Pharma Inc making?

Current yearPrevious yearGrowGrow %
Making money-$12.5m-$11.3m-$1.2m-10.0%
Net Profit Margin-803.1%-18.1%--

How much money comes from the company's main activities?

3. Financial Health of aTyr Pharma Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#398 / 1031

Most Revenue
#633 / 1031

Most Profit
#623 / 1031

Most Efficient
#801 / 1031

What can you expect buying and holding a share of aTyr Pharma Inc? (5 min.)

Welcome investor! aTyr Pharma Inc's management wants to use your money to grow the business. In return you get a share of aTyr Pharma Inc.

What can you expect buying and holding a share of aTyr Pharma Inc?

First you should know what it really means to hold a share of aTyr Pharma Inc. And how you can make/lose money.

Speculation

The Price per Share of aTyr Pharma Inc is €1.83. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of aTyr Pharma Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in aTyr Pharma Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €1.23. Based on the TTM, the Book Value Change Per Share is €0.07 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.13 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of aTyr Pharma Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.22-11.9%-0.19-10.2%-0.17-9.1%-0.13-7.1%-0.13-7.1%
Usd Book Value Change Per Share-0.11-6.2%0.073.9%-0.14-7.6%0.074.1%0.074.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.11-6.2%0.073.9%-0.14-7.6%0.074.1%0.074.1%
Usd Price Per Share1.40-1.77-3.33-3.62-3.62-
Price to Earnings Ratio-1.60--2.39--4.97--5.87--5.87-
Price-to-Total Gains Ratio-12.22--15.06--24.07--45.45--45.45-
Price to Book Ratio1.04-1.18-2.64-4.78-4.78-
Price-to-Total Gains Ratio-12.22--15.06--24.07--45.45--45.45-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.979511
Number of shares505
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.070.07
Usd Total Gains Per Share0.070.07
Gains per Quarter (505 shares)35.7537.47
Gains per Year (505 shares)143.01149.86
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
101431330150140
202862760300290
304294190450440
405725620599590
507157050749740
608588480899890
701001991010491040
8011441134011991190
9012871277013491340
10014301420014991490

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%1.017.00.05.6%1.017.00.05.6%1.017.00.05.6%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%5.013.00.027.8%5.013.00.027.8%5.013.00.027.8%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.018.00.0%0.00.018.00.0%0.00.018.00.0%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%5.013.00.027.8%5.013.00.027.8%5.013.00.027.8%

Fundamentals of aTyr Pharma Inc

About aTyr Pharma Inc

aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. Its lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase III clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for treatment of other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and connective tissue disease related ILD. The company is developing ATYR0101, a fusion protein derived from a domain of aspartyl-tRNA synthetase that is in preclinical development for the treatment of fibrosis; and ATYR0750, a domain of alanyl-tRNA synthetase for the treatment of liver disorders. It has collaboration and license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of efzofitimod for ILDs in Japan. aTyr Pharma, Inc. was incorporated in 2005 and is headquartered in San Diego, California.

Fundamental data was last updated by Penke on 2024-03-27 14:52:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of aTyr Pharma Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit aTyr Pharma Inc earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare aTyr Pharma Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that €0.00 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of aTyr Pharma Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-803.1%+803.1%
TTM-803.1%YOY-18.1%-785.0%
TTM-803.1%5Y-1,032.7%+229.6%
5Y-1,032.7%10Y-1,032.7%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--159.2%+159.2%
TTM-803.1%-202.3%-600.8%
YOY-18.1%-263.0%+244.9%
5Y-1,032.7%-452.4%-580.3%
10Y-1,032.7%-589.0%-443.7%
1.1.2. Return on Assets

Shows how efficient aTyr Pharma Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare aTyr Pharma Inc to the Biotechnology industry mean.
  • -12.2% Return on Assets means that aTyr Pharma Inc generated €-0.12 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of aTyr Pharma Inc:

  • The MRQ is -12.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -9.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.2%TTM-9.8%-2.4%
TTM-9.8%YOY-11.5%+1.7%
TTM-9.8%5Y-11.2%+1.4%
5Y-11.2%10Y-11.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.2%-12.5%+0.3%
TTM-9.8%-12.2%+2.4%
YOY-11.5%-11.2%-0.3%
5Y-11.2%-13.3%+2.1%
10Y-11.2%-14.6%+3.4%
1.1.3. Return on Equity

Shows how efficient aTyr Pharma Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare aTyr Pharma Inc to the Biotechnology industry mean.
  • -16.3% Return on Equity means aTyr Pharma Inc generated €-0.16 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of aTyr Pharma Inc:

  • The MRQ is -16.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -12.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-16.3%TTM-12.6%-3.7%
TTM-12.6%YOY-13.6%+1.0%
TTM-12.6%5Y-14.3%+1.8%
5Y-14.3%10Y-14.3%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-16.3%-16.0%-0.3%
TTM-12.6%-15.8%+3.2%
YOY-13.6%-13.9%+0.3%
5Y-14.3%-18.2%+3.9%
10Y-14.3%-19.1%+4.8%

1.2. Operating Efficiency of aTyr Pharma Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient aTyr Pharma Inc is operating .

  • Measures how much profit aTyr Pharma Inc makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare aTyr Pharma Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of aTyr Pharma Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-19.1%+19.1%
TTM-5Y-818.4%+818.4%
5Y-818.4%10Y-818.4%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--299.5%+299.5%
TTM--208.5%+208.5%
YOY-19.1%-280.2%+261.1%
5Y-818.4%-459.9%-358.5%
10Y-818.4%-596.9%-221.5%
1.2.2. Operating Ratio

Measures how efficient aTyr Pharma Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are €0.00 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of aTyr Pharma Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM9.184-9.184
TTM9.184YOY0.441+8.743
TTM9.1845Y10.855-1.671
5Y10.85510Y10.8550.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.817-2.817
TTM9.1843.181+6.003
YOY0.4413.609-3.168
5Y10.8555.554+5.301
10Y10.8557.396+3.459

1.3. Liquidity of aTyr Pharma Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if aTyr Pharma Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 6.27 means the company has €6.27 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of aTyr Pharma Inc:

  • The MRQ is 6.274. The company is very able to pay all its short-term debts. +2
  • The TTM is 8.151. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.274TTM8.151-1.877
TTM8.151YOY9.978-1.827
TTM8.1515Y8.682-0.531
5Y8.68210Y8.6820.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.2743.987+2.287
TTM8.1514.440+3.711
YOY9.9785.569+4.409
5Y8.6826.158+2.524
10Y8.6826.492+2.190
1.3.2. Quick Ratio

Measures if aTyr Pharma Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare aTyr Pharma Inc to the Biotechnology industry mean.
  • A Quick Ratio of 4.61 means the company can pay off €4.61 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of aTyr Pharma Inc:

  • The MRQ is 4.607. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 6.631. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.607TTM6.631-2.025
TTM6.631YOY8.353-1.722
TTM6.6315Y6.277+0.354
5Y6.27710Y6.2770.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.6073.653+0.954
TTM6.6314.158+2.473
YOY8.3535.515+2.838
5Y6.2776.012+0.265
10Y6.2776.206+0.071

1.4. Solvency of aTyr Pharma Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of aTyr Pharma Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare aTyr Pharma Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.25 means that aTyr Pharma Inc assets are financed with 25.0% credit (debt) and the remaining percentage (100% - 25.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of aTyr Pharma Inc:

  • The MRQ is 0.250. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.216. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.250TTM0.216+0.034
TTM0.216YOY0.154+0.062
TTM0.2165Y0.198+0.019
5Y0.19810Y0.1980.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2500.336-0.086
TTM0.2160.330-0.114
YOY0.1540.267-0.113
5Y0.1980.367-0.169
10Y0.1980.378-0.180
1.4.2. Debt to Equity Ratio

Measures if aTyr Pharma Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare aTyr Pharma Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 33.3% means that company has €0.33 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of aTyr Pharma Inc:

  • The MRQ is 0.333. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.276. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.333TTM0.276+0.057
TTM0.276YOY0.192+0.084
TTM0.2765Y0.266+0.010
5Y0.26610Y0.2660.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3330.376-0.043
TTM0.2760.398-0.122
YOY0.1920.334-0.142
5Y0.2660.431-0.165
10Y0.2660.476-0.210

2. Market Valuation of aTyr Pharma Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings aTyr Pharma Inc generates.

  • Above 15 is considered overpriced but always compare aTyr Pharma Inc to the Biotechnology industry mean.
  • A PE ratio of -1.60 means the investor is paying €-1.60 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of aTyr Pharma Inc:

  • The EOD is -2.271. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.601. Based on the earnings, the company is expensive. -2
  • The TTM is -2.395. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.271MRQ-1.601-0.670
MRQ-1.601TTM-2.395+0.794
TTM-2.395YOY-4.974+2.579
TTM-2.3955Y-5.875+3.480
5Y-5.87510Y-5.8750.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.271-2.697+0.426
MRQ-1.601-2.422+0.821
TTM-2.395-2.709+0.314
YOY-4.974-4.116-0.858
5Y-5.875-6.257+0.382
10Y-5.875-6.478+0.603
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of aTyr Pharma Inc:

  • The EOD is -3.026. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.133. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -6.521. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.026MRQ-2.133-0.893
MRQ-2.133TTM-6.521+4.388
TTM-6.521YOY-5.320-1.201
TTM-6.5215Y-5.680-0.841
5Y-5.68010Y-5.6800.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.026-3.344+0.318
MRQ-2.133-2.939+0.806
TTM-6.521-3.486-3.035
YOY-5.320-5.592+0.272
5Y-5.680-8.464+2.784
10Y-5.680-8.872+3.192
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of aTyr Pharma Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.04 means the investor is paying €1.04 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of aTyr Pharma Inc:

  • The EOD is 1.482. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.045. Based on the equity, the company is underpriced. +1
  • The TTM is 1.177. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.482MRQ1.045+0.437
MRQ1.045TTM1.177-0.132
TTM1.177YOY2.643-1.467
TTM1.1775Y4.781-3.605
5Y4.78110Y4.7810.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.4822.198-0.716
MRQ1.0452.042-0.997
TTM1.1772.121-0.944
YOY2.6432.907-0.264
5Y4.7813.682+1.099
10Y4.7814.114+0.667
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of aTyr Pharma Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.1060.065-261%-0.129+22%0.069-254%0.069-254%
Book Value Per Share--1.2351.380-11%1.136+9%0.943+31%0.943+31%
Current Ratio--6.2748.151-23%9.978-37%8.682-28%8.682-28%
Debt To Asset Ratio--0.2500.216+16%0.154+63%0.198+27%0.198+27%
Debt To Equity Ratio--0.3330.276+21%0.192+74%0.266+25%0.266+25%
Dividend Per Share----0%-0%-0%-0%
Eps---0.201-0.173-14%-0.155-23%-0.120-41%-0.120-41%
Free Cash Flow Per Share---0.151-0.128-16%-0.148-2%-0.111-27%-0.111-27%
Free Cash Flow To Equity Per Share---0.069-0.043-37%-0.130+89%0.023-403%0.023-403%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---8.826--------
Intrinsic Value_10Y_min---7.514--------
Intrinsic Value_1Y_max---0.573--------
Intrinsic Value_1Y_min---0.563--------
Intrinsic Value_3Y_max---1.959--------
Intrinsic Value_3Y_min---1.866--------
Intrinsic Value_5Y_max---3.632--------
Intrinsic Value_5Y_min---3.350--------
Market Cap123982500.000+30%87397500.000110678093.750-21%208500625.000-58%226527770.833-61%226527770.833-61%
Net Profit Margin----8.0310%-0.1810%-10.3270%-10.3270%
Operating Margin----0%-0.1910%-8.1840%-8.1840%
Operating Ratio---9.184-100%0.441-100%10.855-100%10.855-100%
Pb Ratio1.482+30%1.0451.177-11%2.643-60%4.781-78%4.781-78%
Pe Ratio-2.271-42%-1.601-2.395+50%-4.974+211%-5.875+267%-5.875+267%
Price Per Share1.830+30%1.2901.634-21%3.078-58%3.344-61%3.344-61%
Price To Free Cash Flow Ratio-3.026-42%-2.133-6.521+206%-5.320+149%-5.680+166%-5.680+166%
Price To Total Gains Ratio-17.342-42%-12.225-15.058+23%-24.074+97%-45.447+272%-45.447+272%
Quick Ratio--4.6076.631-31%8.353-45%6.277-27%6.277-27%
Return On Assets---0.122-0.098-20%-0.115-6%-0.112-8%-0.112-8%
Return On Equity---0.163-0.126-23%-0.136-16%-0.143-12%-0.143-12%
Total Gains Per Share---0.1060.065-261%-0.129+22%0.069-254%0.069-254%
Usd Book Value--90472863.376101108949.997-11%83283135.828+9%69090853.323+31%69090853.323+31%
Usd Book Value Change Per Share---0.1140.071-261%-0.140+22%0.074-254%0.074-254%
Usd Book Value Per Share--1.3351.492-11%1.229+9%1.020+31%1.020+31%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.218-0.187-14%-0.167-23%-0.129-41%-0.129-41%
Usd Free Cash Flow---11079350.650-9359296.212-16%-10882094.407-2%-7207617.003-35%-7207617.003-35%
Usd Free Cash Flow Per Share---0.164-0.138-16%-0.161-2%-0.120-27%-0.120-27%
Usd Free Cash Flow To Equity Per Share---0.074-0.047-37%-0.141+89%0.025-403%0.025-403%
Usd Market Cap134111870.250+30%94537875.750119720494.009-21%225535126.063-58%245035089.710-61%245035089.710-61%
Usd Price Per Share1.980+30%1.3951.767-21%3.329-58%3.617-61%3.617-61%
Usd Profit---14760467.154-12597648.703-15%-11334858.737-23%-8741221.095-41%-8741221.095-41%
Usd Revenue---88252.793-100%2596582.179-100%1195704.510-100%1195704.510-100%
Usd Total Gains Per Share---0.1140.071-261%-0.140+22%0.074-254%0.074-254%
 EOD+5 -3MRQTTM+4 -27YOY+13 -185Y+7 -2410Y+7 -24

3.2. Fundamental Score

Let's check the fundamental score of aTyr Pharma Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.271
Price to Book Ratio (EOD)Between0-11.482
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than14.607
Current Ratio (MRQ)Greater than16.274
Debt to Asset Ratio (MRQ)Less than10.250
Debt to Equity Ratio (MRQ)Less than10.333
Return on Equity (MRQ)Greater than0.15-0.163
Return on Assets (MRQ)Greater than0.05-0.122
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of aTyr Pharma Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.918
Ma 20Greater thanMa 501.686
Ma 50Greater thanMa 1001.634
Ma 100Greater thanMa 2001.400
OpenGreater thanClose1.810
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets120,653
Total Liabilities30,183
Total Stockholder Equity90,658
 As reported
Total Liabilities 30,183
Total Stockholder Equity+ 90,658
Total Assets = 120,653

Assets

Total Assets120,653
Total Current Assets102,992
Long-term Assets17,661
Total Current Assets
Cash And Cash Equivalents 22,544
Short-term Investments 75,622
Total Current Assets  (as reported)102,992
Total Current Assets  (calculated)98,166
+/- 4,826
Long-term Assets
Property Plant Equipment 14,046
Long-term Assets Other 3,615
Long-term Assets  (as reported)17,661
Long-term Assets  (calculated)17,661
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities16,416
Long-term Liabilities13,767
Total Stockholder Equity90,658
Total Current Liabilities
Accounts payable 3,529
Total Current Liabilities  (as reported)16,416
Total Current Liabilities  (calculated)3,529
+/- 12,887
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt15,095
Long-term Liabilities  (as reported)13,767
Long-term Liabilities  (calculated)15,095
+/- 1,328
Total Stockholder Equity
Total Stockholder Equity (as reported)90,658
Total Stockholder Equity (calculated)0
+/- 90,658
Other
Capital Stock63
Common Stock Shares Outstanding 58,560
Net Invested Capital 90,658
Net Working Capital 86,576
Property Plant and Equipment Gross 18,667



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
> Total Assets 
43,745
36,188
54,447
47,562
41,636
38,726
55,128
48,995
123,916
115,537
104,776
96,016
96,055
95,786
136,838
132,747
125,069
120,653
120,653125,069132,747136,83895,78696,05596,016104,776115,537123,91648,99555,12838,72641,63647,56254,44736,18843,745
   > Total Current Assets 
39,144
31,925
50,374
43,840
38,218
35,531
52,134
46,407
121,572
113,569
103,117
93,355
84,633
80,871
119,447
114,431
107,298
102,992
102,992107,298114,431119,44780,87184,63393,355103,117113,569121,57246,40752,13435,53138,21843,84050,37431,92539,144
       Cash And Cash Equivalents 
17,341
9,210
39,453
21,632
18,151
16,952
12,587
2,192
59,742
2,336
8,324
8,484
18,359
9,981
20,690
12,313
9,787
22,544
22,5449,78712,31320,6909,98118,3598,4848,3242,33659,7422,19212,58716,95218,15121,63239,4539,21017,341
       Short-term Investments 
20,723
21,934
10,376
19,802
17,995
14,737
38,050
41,869
56,612
105,575
90,342
80,070
59,015
56,165
93,695
96,268
92,344
75,622
75,62292,34496,26893,69556,16559,01580,07090,342105,57556,61241,86938,05014,73717,99519,80210,37621,93420,723
       Net Receivables 
0
0
0
831
245
39
89
90
129
435
426
426
873
11,775
0
1,287
0
0
001,287011,775873426426435129908939245831000
       Other Current Assets 
0
0
0
0
0
2,000
0
0
0
0
0
4,375
6,555
2,950
3,437
0
0
0
0003,4372,9506,5554,375000002,00000000
   > Long-term Assets 
4,601
4,263
4,073
3,722
3,418
3,194
2,994
2,588
2,186
1,810
1,659
2,661
9,014
14,700
17,391
18,316
17,771
17,661
17,66117,77118,31617,39114,7009,0142,6611,6591,8102,1862,5882,9943,1943,4183,7224,0734,2634,601
       Property Plant Equipment 
4,380
4,091
3,924
3,597
3,278
2,982
2,760
2,436
2,186
1,810
1,483
1,753
9,014
11,557
14,057
14,825
14,247
14,046
14,04614,24714,82514,05711,5579,0141,7531,4831,8102,1862,4362,7602,9823,2783,5973,9244,0914,380
       Other Assets 
221
172
149
125
140
213
234
152
158
158
176
908
2,408
3,358
0
3,491
0
0
003,49103,3582,408908176158158152234213140125149172221
> Total Liabilities 
17,009
15,162
12,480
11,624
9,638
7,242
5,596
8,190
6,477
6,411
6,402
9,558
19,049
24,502
27,140
26,695
26,866
30,183
30,18326,86626,69527,14024,50219,0499,5586,4026,4116,4778,1905,5967,2429,63811,62412,48015,16217,009
   > Total Current Liabilities 
11,828
12,923
10,445
9,799
8,033
5,864
4,451
7,284
5,820
6,013
6,269
9,260
11,213
13,862
13,654
12,368
12,881
16,416
16,41612,88112,36813,65413,86211,2139,2606,2696,0135,8207,2844,4515,8648,0339,79910,44512,92311,828
       Short Long Term Debt 
7,844
8,737
6,866
4,976
3,061
0
0
0
0
0
0
70
0
0
0
0
0
0
000000700000003,0614,9766,8668,7377,844
       Accounts payable 
1,324
847
748
603
1,352
1,431
1,161
2,224
900
1,031
1,563
1,674
3,129
3,106
3,965
516
2,043
3,529
3,5292,0435163,9653,1063,1291,6741,5631,0319002,2241,1611,4311,3526037488471,324
       Other Current Liabilities 
352
208
143
604
53
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000053604143208352
   > Long-term Liabilities 
5,181
2,239
2,035
1,825
1,605
1,378
1,145
906
657
398
133
298
7,836
10,640
13,486
14,327
13,985
13,767
13,76713,98514,32713,48610,6407,8362981333986579061,1451,3781,6051,8252,0352,2395,181
       Long term Debt 
2,742
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000002,742
       Capital Lease Obligations Min Short Term Debt
3,168
2,994
2,815
2,632
2,439
2,239
2,035
1,825
1,606
1,378
1,145
1,204
8,651
11,534
14,287
15,391
15,218
15,095
15,09515,21815,39114,28711,5348,6511,2041,1451,3781,6061,8252,0352,2392,4392,6322,8152,9943,168
> Total Stockholder Equity
26,736
21,186
42,128
36,100
32,161
31,650
49,702
40,976
117,439
109,126
98,550
86,635
77,006
71,284
109,879
106,237
98,390
90,658
90,65898,390106,237109,87971,28477,00686,63598,550109,126117,43940,97649,70231,65032,16136,10042,12821,18626,736
   Common Stock
50
4
9
9
10
11
16
16
28
28
28
28
29
29
0
57
0
0
005702929282828281616111099450
   Retained Earnings Total Equity000000000000000000
   Accumulated Other Comprehensive Income 000000000000000000
   Capital Surplus 000000000000000000
   Treasury Stock000000000000000000
   Other Stockholders Equity 00-3330-433-669-810-759-263-69-61-57-43-42-44-53-40-33



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue353
Cost of Revenue--
Gross Profit-353
 
Operating Income (+$)
Gross Profit-
Operating Expense-55,272
Operating Income-54,919-55,272
 
Operating Expense (+$)
Research Development42,293
Selling General Administrative12,979
Selling And Marketing Expenses-
Operating Expense55,27255,272
 
Net Interest Income (+$)
Interest Income-
Interest Expense--
Other Finance Cost-0
Net Interest Income-
 
Pretax Income (+$)
Operating Income-54,919
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-50,397-59,441
EBIT - interestExpense = 0
-50,389
-50,389
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--50,397
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-50,397
Tax Provision--
Net Income From Continuing Ops-50,397-50,397
Net Income-50,389
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net4,5220
 

Technical Analysis of aTyr Pharma Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of aTyr Pharma Inc. The general trend of aTyr Pharma Inc is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine aTyr Pharma Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of aTyr Pharma Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 2.2 < 2.32 < 2.38.

The bearish price targets are: 1.43 > 1.43 > 1.43.

Tweet this
aTyr Pharma Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of aTyr Pharma Inc. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

aTyr Pharma Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of aTyr Pharma Inc. The current macd is 0.05259947.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the aTyr Pharma Inc price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for aTyr Pharma Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the aTyr Pharma Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
aTyr Pharma Inc Daily Moving Average Convergence/Divergence (MACD) ChartaTyr Pharma Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of aTyr Pharma Inc. The current adx is 28.58.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy aTyr Pharma Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
aTyr Pharma Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of aTyr Pharma Inc. The current sar is 1.72.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
aTyr Pharma Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of aTyr Pharma Inc. The current rsi is 55.92. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
aTyr Pharma Inc Daily Relative Strength Index (RSI) ChartaTyr Pharma Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of aTyr Pharma Inc. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the aTyr Pharma Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
aTyr Pharma Inc Daily Stochastic Oscillator ChartaTyr Pharma Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of aTyr Pharma Inc. The current cci is 64.07.

aTyr Pharma Inc Daily Commodity Channel Index (CCI) ChartaTyr Pharma Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of aTyr Pharma Inc. The current cmo is 12.66.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
aTyr Pharma Inc Daily Chande Momentum Oscillator (CMO) ChartaTyr Pharma Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of aTyr Pharma Inc. The current willr is -55.05617978.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that aTyr Pharma Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
aTyr Pharma Inc Daily Williams %R ChartaTyr Pharma Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of aTyr Pharma Inc.

aTyr Pharma Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of aTyr Pharma Inc. The current atr is 0.09625729.

aTyr Pharma Inc Daily Average True Range (ATR) ChartaTyr Pharma Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of aTyr Pharma Inc. The current obv is -21,510.

aTyr Pharma Inc Daily On-Balance Volume (OBV) ChartaTyr Pharma Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of aTyr Pharma Inc. The current mfi is 44.14.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
aTyr Pharma Inc Daily Money Flow Index (MFI) ChartaTyr Pharma Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for aTyr Pharma Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-09 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-10 00:00:00BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-13 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-14 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-16 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-20 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-21 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-23 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-27 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-28 00:00:00WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-29 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-04 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-12 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-14 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-18 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-21 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-27 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-29 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-03 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-05 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-11 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-19 00:00:00MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-22 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-23 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-25 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-31 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-06 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-07 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-09 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-13 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-19 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-21 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-22 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-23 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-27 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-29 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-04 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-05 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-06 00:00:00BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-07 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-15 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-18 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-19 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-20 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-22 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-25 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-27 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-28 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

aTyr Pharma Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of aTyr Pharma Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.918
Ma 20Greater thanMa 501.686
Ma 50Greater thanMa 1001.634
Ma 100Greater thanMa 2001.400
OpenGreater thanClose1.810
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of aTyr Pharma Inc with someone you think should read this too:
  • Are you bullish or bearish on aTyr Pharma Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about aTyr Pharma Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about aTyr Pharma Inc

I send you an email if I find something interesting about aTyr Pharma Inc.


Comments

How you think about this?

Leave a comment

Stay informed about aTyr Pharma Inc.

Receive notifications about aTyr Pharma Inc in your mailbox!